38. Influence of biologic subtype of inflammatory breast cancer on response to neoadjuvant therapy and cancer outcomes. Issue 9 (September 2016) - Hieken, T.; Murphy, B.; Boughey, J.; Degnim, A.; Glazebrook, K.; Hoskin, T.